Retia Medical

Retia Medical develops and sells advanced algorithms and monitors for guiding care for high-risk surgical and critically ill patients. The Argos Cardiac Output Monitor provides consistent accuracy using Multi-Beat Analysis(TM), rapid setup, and an intuitive user interface while avoiding costly proprietary disposables. Approximately 20 million surgical intensive care patients worldwide could benefit from this technology. Based in White Plains, NY, Retias technology was developed at Michigan State University and Massachusetts Institute of Technology and validated through extensive tests in animals and humans. With the support of a strong advisory board comprised of industry and clinical experts, Retia received FDA 510(k)...

Patient monitoring,signal processing,cardiovascular,software,digital health,hemodynamics,critical care medicine,and cardiac output

Retia medical operates in the Medical equipment manufacturing industry.

Retia medical's revenue is 11m - 100m

Retia medical has 11 - 50 employees.